Integrated Filing — IndAS



General information about company

Scrip Code 539787
NSE Symbol HCG
MSEI Symbol NOTLISTED
ISIN INE075I01017
Name of company HEALTHCARE GLOBAL ENTERPRISES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 19-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 01-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Healthcare
Start date and time of board meeting 19-05-2026   11:30:00
End date and time of board meeting 19-05-2026   22:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 13-02-2025
Indicate Company website link for updated RPT policy of the Company www.hcgoncology.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
The compnay has not defaulted in repayment of loans. The Company has not issued debt securities.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 35,021.00 1,36,530.00
Other income 1,492.00 2,967.00
Total income 36,513.00 1,39,497.00
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 9,513.00 35,864.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (308.00) (548.00)
(d) Employee benefit expense 5,078.00 21,192.00
(e) Finance costs 2,019.00 8,646.00
(f) Depreciation, depletion and amortisation expense 3,130.00 11,980.00
(f) Other Expenses
1 Medical Consultnacy 6,675.00 26,343.00
2 Other Expenses 6,549.00 29,520.00
Total other expenses 13,224.00 55,863.00
Total expenses 32,656.00 1,32,997.00
3 Total profit before exceptional items and tax 3,857.00 6,500.00
4 Exceptional items (4,752.00) (5,538.00)
5 Total profit before tax (895.00) 962.00
6 Tax expense
7 Current tax (820.00) 404.00
8 Deferred tax (228.00) (900.00)
9 Total tax expenses (1,048.00) (496.00)
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 153.00 1,458.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 153.00 1,458.00
17 Other comprehensive income net of taxes (11.00) 8.00
18 Total Comprehensive Income for the period 142.00 1,466.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 14,930.00 14,930.00
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 1,45,548.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.11 1.03
Diluted earnings (loss) per share from continuing operations 0.11 1.02
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.11 1.03
Diluted earnings (loss) per share from continuing and discontinued operations 0.11 1.02
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1,02,521.00
Capital work-in-progress 1,379.00
Investment property 0.00
Goodwill 9,014.00
Other intangible assets 688.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 70,370.00
Trade receivables, non-current 0.00
Loans, non-current 201.00
Other non-current financial assets
1 Other Financial Assets 8,564.00
Total of other non-current financial assets 8,564.00
Total non-current financial assets 79,135.00
Deferred tax assets (net) 381.00
Other non-current assets
1 Other tax Asset(net) 6,913.00
2 Other Non - Current Assest 3,539.00
Total of other non-current assets 10,452.00
Total non-current assets 2,03,570.00
2 Current assets
Inventories 2,524.00
Current financial asset
Current investments 0.00
Trade receivables, current 26,215.00
Cash and cash equivalents 47,411.00
Bank balance other than cash and cash equivalents 0.00
Loans, current 156.00
Other current financial assets
Total of other current financial assets 6,121.00
Total current financial assets 79,903.00
Current tax assets (net) 0.00
Other current assets
1 Other current assets 2,510.00
Total of other current assets 2,510.00
Total current assets 84,937.00
3 Non-current assets classified as held for sale 3,227.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 2,91,734.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 14,930.00
Other equity 1,45,548.00
Total equity attributable to owners of parent 1,60,478.00
Non controlling interest
Total equity 1,60,478.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 31,506.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 other financial liabilties 904.00
2 Lease liabilities 40,848.00
Total of other non-current financial liabilities 41,752.00
Total non-current financial liabilities 73,258.00
Provisions, non-current 1,632.00
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 Other non current liabilities 3,325.00
Total of other non-current liabilities 3,325.00
Total non-current liabilities 78,215.00
Current liabilities
Current financial liabilities
Borrowings, current 25,199.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 421.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 15,801.00
Total Trade payable 16,222.00
Other current financial liabilities
1 Lease liabilities 4,640.00
2 other financial liabilities 2,730.00
Total of other current financial liabilities 7,370.00
Total current financial liabilities 48,791.00
Other current liabilities 2,290.00
1 Other current liabilities 2,290.00
Total of other current liabilities 2,290.00
Provisions, current 1,711.00
Current tax liabilities (Net) 249.00
Deferred government grants, Current
Total current liabilities 53,041.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 1,31,256.00
Total equity and liabilites 2,91,734.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of the defined benefit plans (14.00) 11.00
2 Income tax effect on above 3.00 (3.00)
Total Amount of items that will not be reclassified to profit and loss (11.00) 8.00
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
1 Effective portion of gain on hedging instruments in cash flow hedge 0.00 0.00
2 Income tax effect on above 0.00 0.00
Total Amount of items that will be reclassified to profit and loss 0.00 0.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income (11.00) 8.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 962.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 8,646.00
Adjustments for decrease (increase) in inventories (548.00)
Adjustments for decrease (increase) in trade receivables, current (1,350.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 574.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (783.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 11,980.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 510.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (21.00)
Adjustments for dividend income 0.00
Adjustments for interest income 1,783.00
Adjustments for share-based payments (5,685.00)
Adjustments for fair value losses (gains) (6.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 4,498.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 16,032.00
Net cash flows from (used in) operations 16,994.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 975.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 16,019.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 15,224.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 15,417.00
Proceeds from sales of investment property 196.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 2,032.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 20,832.00
Net cash flows from (used in) investing activities (7,581.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 44,402.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 9,149.00
Repayments of borrowings 7,360.00
Payments of lease liabilities 7,749.00
Dividends paid 0.00
Interest paid 4,821.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 33,621.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 42,059.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 42,059.00
Cash and cash equivalents cash flow statement at beginning of period (12,175.00)
Cash and cash equivalents cash flow statement at end of period 29,884.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 B S R & Co. LLP Yes 31-07-2026


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Rights Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 27-03-2026
Amount Raised 42,468.18
Report filed for Quarter ended 31-03-2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable Care Ratings Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation false
Comments of the Audit Committee after review
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Pre-payment and/ or repayment of all, or a portion of, certain outstanding borrowings availed by our Company and by one of our wholly owned Subsidiaries, HCG NCHRI Oncology LLP NA 17,000.00 0.00 0.00 0.00
2 Part-payment of consideration for acquisition of 34.00% additional stake in equity share capital of Vizag Hospital and Cancer Research Center Private Limited, one of our existing Subsidiaries NA 15,403.96 0.00 0.00 0.00
3 General corporate purposes*# NA 9,556.87 0.00 0.00 0.00
4 Issue related expenses** NA 507.35 0.00 0.00 0.00


Signatory Details

Name of signatory Sunu Manuel
Designation of person Company Secretary
Place Bangalore
Date 19-05-2026




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Sale of goods or services 170.00 Approved 0.00 19-03-2026 5.61 21.10 19.40 Any other NA 0 Not Applicable
2 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Purchase of goods or services 150.00 Approved 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable
3 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Any other transaction Expense from diagnostic and other medical services 12.50 Approved 0.00 19-03-2026 3.80 13.70 11.20 Any other NA 0 Not Applicable
4 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Any other transaction Other expenses cross-charged to subsidiaries 304.90 Approved 0.00 19-03-2026 304.90 0.00 0.00 Any other NA 0 Not Applicable
5 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Any other transaction Payments on behalf of 429.20 Approved 0.00 19-03-2026 429.20 608.80 794.20 Any other NA 0 Not Applicable
6 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Any other transaction Corporate guarantee commission income received 0.00 Approved 27.70 19-03-2026 27.70 0.00 0.00 Any other NA 0 Not Applicable
7 HCG Medi-surge Hospitals Private Limited HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 26.62 9.41 10.22 Any other NA 0 Not Applicable
8 HCG Medi-surge Hospitals Private Limited HCG Oncology LLP Subsidiary LLP Sale of fixed assets 0.00 Not Applicable 0.00 19-03-2026 0.00 0.39 0.00 Any other NA 0 Not Applicable
9 HCG Medi-surge Hospitals Private Limited HCG Oncology LLP Subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 0.00 19-03-2026 0.00 1.40 0.00 Any other NA 0 Not Applicable
10 HCG Medi-surge Hospitals Private Limited HCG Oncology LLP Subsidiary LLP Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.00 2.64 0.00 Any other NA 0 Not Applicable
11 HCG Medi-surge Hospitals Private Limited HCG Oncology LLP Subsidiary LLP Purchase of goods or services 0.00 Not Applicable 0.00 19-03-2026 3.45 7.55 3.45 Any other NA 0 Not Applicable
12 HCG Medi-surge Hospitals Private Limited Astha Oncology Private Limited Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Medical Consultant fee 3,168.71 Approved 0.00 19-03-2026 3,168.71 404.67 567.67 Any other NA 0 Not Applicable
13 HCG Medi-surge Hospitals Private Limited Astha Oncology Private Limited Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.23 0.00 0.23 Any other NA 0 Not Applicable
14 HCG Medi-surge Hospitals Private Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 0.00 19-03-2026 1.72 3.25 4.97 Any other NA 0 Not Applicable
15 HCG Medi-surge Hospitals Private Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.00 0.27 0.00 Any other NA 0 Not Applicable
16 HCG Medi-surge Hospitals Private Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Purchase of goods or services 352.02 Approved 0.00 19-03-2026 352.02 313.05 342.09 Any other NA 0 Not Applicable
17 HCG Medi-surge Hospitals Private Limited International Human Development and Upliftment Academy (Trust) Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction CSR contribution to 17.74 Approved 0.00 19-03-2026 17.74 0.00 0.00 Any other NA 0 Not Applicable
18 HealthCare Global Enterprises Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 30.00 Approved 0.00 19-03-2026 26.10 0.00 0.00 Any other NA 0 Not Applicable
19 HealthCare Global Enterprises Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Income from diagnostic and other medical services 100.00 Approved 0.00 19-03-2026 22.30 18.74 0.00 Any other NA 0 Not Applicable
20 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Sale of goods or services 15.00 Approved 0.00 19-03-2026 1.12 0.00 0.00 Any other NA 0 Not Applicable
21 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Sale of fixed assets 50.00 Approved 0.00 19-03-2026 0.00 3.35 7.90 Any other NA 0 Not Applicable
22 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Purchase of goods or services 70.00 Approved 0.00 19-03-2026 33.60 6.00 22.60 Any other NA 0 Not Applicable
23 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Corporate guarantee commission income received 10.50 Approved 12.80 19-03-2026 27.70 1,551.40 0.00 Any other NA 0 Not Applicable
24 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0.00 Approved 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable
25 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 198.60 Approved 0.00 19-03-2026 178.80 0.00 0.00 Any other NA 0 Not Applicable
26 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 4.70 Approved 0.00 19-03-2026 4.70 211.90 18.27 Any other NA 0 Not Applicable
27 HCG Oncology LLP Dr. Rajiv Gopinath Bhat Partner Any other transaction Medical Service 610.00 Approved 0.00 19-03-2026 307.67 87.26 0.40 Any other NA 0 Not Applicable
28 HCG Oncology LLP HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 1.08 2.58 0.00 Any other NA 0 Not Applicable
29 HCG Oncology LLP HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.00 0.19 0.00 Any other NA 0 Not Applicable
30 HCG Oncology LLP HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Other expenses cross-charged to subsidiaries 0.00 Not Applicable 0.00 19-03-2026 0.43 0.00 0.62 Any other NA 0 Not Applicable
31 HCG Oncology LLP HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Any other transaction Expense from diagnostic and other medical services 0.00 Not Applicable 0.00 19-03-2026 5.23 8.23 12.30 Any other NA 0 Not Applicable
32 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Purchase of goods or services 0.00 Not Applicable 0.00 19-03-2026 1.29 0.00 0.00 Any other NA 0 Not Applicable
33 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Any other transaction Expense from diagnostic and other medical services 0.00 Not Applicable 0.00 19-03-2026 2,197.02 116.09 0.80 Any other NA 0 Not Applicable
34 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Any other transaction Recovery of loans given to 0.00 Not Applicable 0.00 19-03-2026 1,511.19 1,511.19 0.00 Any other NA 0 Not Applicable Loan 10.0 1 Unsecured As per the business needs
35 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Interest received 0.00 Not Applicable 0.00 19-03-2026 510.40 0.00 0.00 Any other NA 0 Not Applicable Loan 10.0 1 Unsecured As per the business needs
36 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Any other transaction Interest accrued on loan/ capital contribution by subsidiaries 0.00 Not Applicable 0.00 19-03-2026 293.50 293.50 0.00 Any other NA 0 Not Applicable
37 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Any other transaction Other expenses cross-charged to subsidiaries 0.00 Not Applicable 0.00 19-03-2026 304.40 0.00 0.00 Any other NA 0 Not Applicable
38 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 0.00 19-03-2026 1,358.30 3,023.40 2,228.80 Any other NA 0 Not Applicable
39 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Investment 2,200.00 Approved 0.00 19-03-2026 2,200.00 6,470.50 8,670.50 Any other NA 0 Not Applicable
40 HCG NCHRI Oncology LLP Suchirayu Health Care Solutions Limited Fellow Subsidiary Any other transaction Expense from diagnostic and other medical services 0.00 Not Applicable 0.00 19-03-2026 229.42 129.31 78.27 Any other NA 0 Not Applicable
41 HCG NCHRI Oncology LLP Malnad Hospital & Institute of Oncology Private Limited Fellow Subsidiary Any other transaction Expense from diagnostic and other medical services 0.00 Not Applicable 0.00 19-03-2026 3.48 1.49 0.71 Any other NA 0 Not Applicable
42 HCG NCHRI Oncology LLP BACC Healthcare Private Limited Fellow Subsidiary Any other transaction Expense from diagnostic and other medical services 0.00 Not Applicable 0.00 19-03-2026 10.98 20.40 30.60 Any other NA 0 Not Applicable
43 HCG NCHRI Oncology LLP HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Fellow Subsidiary Any other transaction Expense from diagnostic and other medical services 0.00 Not Applicable 0.00 19-03-2026 254.26 469.93 399.71 Any other NA 0 Not Applicable
44 HCG NCHRI Oncology LLP HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Fellow Subsidiary Any other transaction Expense from diagnostic and other medical services 0.00 Not Applicable 0.00 19-03-2026 1.61 3.37 4.66 Any other NA 0 Not Applicable
45 HCG NCHRI Oncology LLP HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Fellow Subsidiary Any other transaction Expense from diagnostic and other medical services 0.00 Not Applicable 0.00 19-03-2026 211.00 0.00 0.00 Any other NA 0 Not Applicable
46 HCG NCHRI Oncology LLP HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Fellow Subsidiary Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 34.09 818.07 515.10 Any other NA 0 Not Applicable
47 HCG NCHRI Oncology LLP HCG Manavata Oncology LLP Fellow Subsidiary Loan 0.00 Not Applicable 0.00 19-03-2026 0.00 750.00 755.73 Any other NA 0 Not Applicable
48 HCG NCHRI Oncology LLP HCG Manavata Oncology LLP Fellow Subsidiary Interest received 0.00 Not Applicable 0.00 19-03-2026 37.60 0.00 0.00 Any other NA 0 Not Applicable
49 HealthCare Global Enterprises Limited HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 100.00 Approved 0.00 19-03-2026 56.85 191.73 58.40 Any other NA 0 Not Applicable
50 HealthCare Global Enterprises Limited HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Other payable 0.00 Approved 0.00 19-03-2026 0.00 2.20 2.20 Any other NA 0 Not Applicable
51 HCG Manavata Oncology LLP HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.00 1.00 1.00 Any other NA 0 Not Applicable
52 BACC Healthcare Private Limited HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Other payable 0.00 Not Applicable 0.00 19-03-2026 0.00 0.01 0.00 Any other NA 0 Not Applicable
53 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Fellow Subsidiary Sale of goods or services 12.50 Approved 30.00 19-03-2026 27.40 0.60 9.90 Any other NA 0 Not Applicable
54 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Fellow Subsidiary Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 1.10 Approved 0.00 19-03-2026 1.10 0.00 0.00 Any other NA 0 Not Applicable
55 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Fellow Subsidiary Any other transaction Other expenses cross-charged to subsidiaries 64.70 Approved 0.00 19-03-2026 64.70 120.60 31.30 Any other NA 0 Not Applicable
56 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Fellow Subsidiary Any other transaction Interest accrued on loan/ capital contribution by subsidiaries 0.00 Not Applicable 0.00 19-03-2026 0.00 30.00 30.00 Any other NA 0 Not Applicable
57 Malnad Hospital & Institute of Oncology Private Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent charges 0.00 Not Applicable 0.00 19-03-2026 15.12 0.00 0.00 Any other NA 0 Not Applicable
58 Malnad Hospital & Institute of Oncology Private Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Advance 0.00 Not Applicable 0.00 19-03-2026 12.00 86.76 93.86 Any other NA 0 Not Applicable
59 Malnad Hospital & Institute of Oncology Private Limited Gutti Malnad Hospital LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Security Deposit 0.00 Not Applicable 0.00 19-03-2026 0.00 35.00 35.00 Any other NA 0 Not Applicable
60 Malnad Hospital & Institute of Oncology Private Limited Gutti Malnad Hospital LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.00 13.50 13.50 Any other NA 0 Not Applicable
61 Malnad Hospital & Institute of Oncology Private Limited Malnad Hi-Tech Diagnostic Centre LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Purchase of goods or services 0.00 Not Applicable 0.00 19-03-2026 6.23 13.86 20.09 Any other NA 0 Not Applicable
62 Malnad Hospital & Institute of Oncology Private Limited Malnad MRI Centre LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Purchase of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.00 0.02 0.02 Any other NA 0 Not Applicable
63 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Loan 0.00 Not Applicable 0.00 19-03-2026 200.00 0.00 200.80 Any other NA 0 Not Applicable Loan 10.0 1 Unsecured As per the business needs
64 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Interest received 0.00 Not Applicable 0.00 19-03-2026 0.80 0.00 0.00 Any other NA 0 Not Applicable Loan 10.0 1 Unsecured As per the business needs
65 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable
66 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 0.00 19-03-2026 12.80 0.00 0.00 Any other NA 0 Not Applicable
67 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Any other transaction Other expenses cross-charged to subsidiaries 0.00 Not Applicable 0.00 19-03-2026 42.80 158.20 204.90 Any other NA 0 Not Applicable
68 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.00 17.10 0.52 Any other NA 0 Not Applicable
69 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Allowance for doubtful trade receivables 0.00 Not Applicable 0.00 19-03-2026 0.00 21.10 21.10 Any other NA 0 Not Applicable
70 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Finance lease income 0.00 Not Applicable 0.00 19-03-2026 196.10 4,009.50 3,894.10 Any other NA 0 Not Applicable
71 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Recovery of loans given to 0.00 Not Applicable 0.00 19-03-2026 1,049.60 1,102.22 0.00 Any other NA 0 Not Applicable Loan 10.0 1 Unsecured As per the business needs
72 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Interest received 0.00 Not Applicable 0.00 19-03-2026 58.90 0.00 0.00 Any other NA 0 Not Applicable Loan 10.0 1 Unsecured As per the business needs
73 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Waiver of unrecognised interest on capital contributions 0.00 Not Applicable 0.00 19-03-2026 1,177.40 0.00 0.00 Any other NA 0 Not Applicable
74 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Corporate guarantee commission income received 0.00 Not Applicable 0.00 19-03-2026 7.40 1,410.70 1,094.70 Any other NA 0 Not Applicable
75 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0.00 Not Applicable 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable
76 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 0.00 19-03-2026 178.20 0.00 0.00 Any other NA 0 Not Applicable
77 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Other expenses cross-charged to subsidiaries 0.00 Not Applicable 0.00 19-03-2026 105.90 1,230.30 4.10 Any other NA 0 Not Applicable
78 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Investment 10,946.00 Approved 0.00 19-03-2026 10,946.00 2,005.10 12,951.10 Any other NA 0 Not Applicable
79 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Return of variable capital contribution 6,456.20 Approved 0.00 19-03-2026 6,456.20 6,662.20 205.90 Any other NA 0 Not Applicable
80 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Interest accrued on loan/ capital contribution by subsidiaries 0.00 Not Applicable 0.00 19-03-2026 0.00 0.00 146.10 Any other NA 0 Not Applicable
81 HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Subsidiary LLP Any other transaction Other payable 0.00 Not Applicable 0.00 19-03-2026 0.00 6.19 3.62 Any other NA 0 Not Applicable
82 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 1.60 136.70 136.90 Any other NA 0 Not Applicable
83 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Lab charges 0.00 Not Applicable 0.00 19-03-2026 1.70 6.60 0.00 Any other NA 0 Not Applicable
84 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Corporate guarantee commission income received 0.00 Not Applicable 0.00 19-03-2026 0.60 276.30 175.20 Any other NA 0 Not Applicable
85 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0.00 Not Applicable 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable
86 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 0.00 19-03-2026 161.80 0.00 0.00 Any other NA 0 Not Applicable
87 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Other expenses cross-charged to subsidiaries 0.00 Not Applicable 0.00 19-03-2026 591.80 529.70 1,315.10 Any other NA 0 Not Applicable
88 HealthCare Global Enterprises Limited Suchirayu Health Care Solutions Limited Subsidiary Company Sale of goods or services 321.00 Not Applicable 0.00 19-03-2026 194.70 123.90 132.10 Any other NA 0 Not Applicable
89 HealthCare Global Enterprises Limited Suchirayu Health Care Solutions Limited Subsidiary Company Purchase of goods or services 58.50 Not Applicable 0.00 19-03-2026 53.20 0.00 51.40 Any other NA 0 Not Applicable
90 HealthCare Global Enterprises Limited Suchirayu Health Care Solutions Limited Subsidiary Company Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 201.00 Approved 0.00 19-03-2026 0.00 0.00 51.40 Any other NA 0 Not Applicable
91 HealthCare Global Enterprises Limited Suchirayu Health Care Solutions Limited Subsidiary Company Any other transaction Payments on behalf of 31.10 Approved 0.00 19-03-2026 31.10 37.00 100.10 Any other NA 0 Not Applicable
92 Suchirayu Health Care Solutions Limited Noth Karnataka Sleep Center Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Revenue Share 0.00 Not Applicable 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable
93 Suchirayu Health Care Solutions Limited Dr Rajendra Ishwarappa Dugani Director Any other transaction Medical Consultant fee 0.00 Not Applicable 0.00 19-03-2026 40.00 9.50 7.80 Any other NA 0 Not Applicable
94 Suchirayu Health Care Solutions Limited Dr Sadashivayya Shadaksharayya Soppimath Director Any other transaction Medical Consultant fee 0.00 Not Applicable 0.00 19-03-2026 14.70 6.90 3.80 Any other NA 0 Not Applicable
95 HealthCare Global Enterprises Limited Vizag Hospital and Cancer Research Center Private Limited Subsidiary Company Sale of goods or services 65.00 Approved 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable
96 HealthCare Global Enterprises Limited Vizag Hospital and Cancer Research Center Private Limited Subsidiary Company Any other transaction Lab charges 25.00 Approved 0.00 19-03-2026 21.10 11.60 32.50 Any other NA 0 Not Applicable
97 HealthCare Global Enterprises Limited Vizag Hospital and Cancer Research Center Private Limited Subsidiary Company Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 25.50 Approved 0.00 19-03-2026 25.50 40.70 31.00 Any other NA 0 Not Applicable
98 Vizag Hospital and Cancer Research Center Private Limited Dr V Murali Krishna Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Medical Consultant fee 0.00 Not Applicable 0.00 19-03-2026 264.17 101.25 39.40 Any other NA 0 Not Applicable
99 Vizag Hospital and Cancer Research Center Private Limited Voonna Srinivas Rao Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent 0.00 Not Applicable 0.00 19-03-2026 3.37 0.00 0.00 Any other NA 0 Not Applicable
100 HealthCare Global Enterprises Limited Healthcare Diwan Chand Imaging LLP Subsidiary LLP Any other transaction Other payable 0.00 Not Applicable 0.00 19-03-2026 0.00 25.30 25.30 Any other NA 0 Not Applicable
101 HealthCare Global Enterprises Limited Healthcare Diwan Chand Imaging LLP Subsidiary LLP Purchase of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.00 246.30 246.30 Any other NA 0 Not Applicable
102 HealthCare Global Enterprises Limited HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Addition to right-of-use asset on lease of equipment 817.20 Approved 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable
103 HealthCare Global Enterprises Limited HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Interset expense on lease liability: 17.90 Approved 0.00 19-03-2026 0.00 0.00 650.10 Any other NA 0 Not Applicable
104 HealthCare Global Enterprises Limited HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Depreciation on right-of-use asset 33.86 Approved 0.00 19-03-2026 33.86 0.00 0.00 Any other NA 0 Not Applicable
105 HealthCare Global Enterprises Limited HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Corporate guarantee commission income received 9.50 Approved 3.00 19-03-2026 11.50 2,177.20 1,907.50 Any other NA 0 Not Applicable
106 HealthCare Global Enterprises Limited HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 40.40 Approved 0.00 19-03-2026 40.40 182.80 223.20 Any other NA 0 Not Applicable
107 HCG Manavata Oncology LLP VASANTRAO RUDRAPPA NAGARKAR MEDICAL FOUNDATION Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent charges 0.00 Not Applicable 0.00 19-03-2026 0.60 0.09 0.09 Any other NA 0 Not Applicable
108 HCG Manavata Oncology LLP RAJNISH VASANTRAO NAGARKAR HUF Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent charges 0.00 Not Applicable 0.00 19-03-2026 1.50 0.24 0.00 Any other NA 0 Not Applicable
109 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Any other transaction Rent charges 471.20 Approved 0.00 19-03-2026 471.20 70.12 0.00 Any other NA 0 Not Applicable
110 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Any other transaction Medical Consultant fee 880.00 Approved 0.00 19-03-2026 796.05 246.07 281.70 Any other NA 0 Not Applicable
111 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Purchase of goods or services 0.00 Not Applicable 0.00 19-03-2026 40.03 0.00 20.52 Any other NA 0 Not Applicable
112 HCG Manavata Oncology LLP KIMS Manavata Multi Speciality Hospital Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Medical Consultant fee 0.00 Not Applicable 0.00 19-03-2026 53.16 0.00 70.04 Any other NA 0 Not Applicable
113 HCG Manavata Oncology LLP HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Subsidiary LLP Purchase of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.00 0.24 0.24 Any other NA 0 Not Applicable
114 HCG Manavata Oncology LLP HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.00 1.00 1.00 Any other NA 0 Not Applicable
115 HCG Manavata Oncology LLP KIMS Manavata Multi Speciality Hospital Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 0.00 59.15 144.58 Any other NA 0 Not Applicable
116 HCG Manavata Oncology LLP VASANTRAO RUDRAPPA NAGARKAR MEDICAL FOUNDATION Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 2.01 0.00 0.00 Any other NA 0 Not Applicable
117 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Sale of goods or services 0.00 Not Applicable 0.00 19-03-2026 7.82 1.03 0.40 Any other NA 0 Not Applicable
118 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Loan 0.00 Not Applicable 0.00 19-03-2026 0.00 755.54 755.54 Any other NA 0 Not Applicable
119 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Interest paid 0.00 Not Applicable 0.00 19-03-2026 37.60 0.00 0.00 Any other NA 0 Not Applicable
120 HealthCare Global Enterprises Limited Nagpur Cancer Hospital and Research Institute Pvt Ltd Subsidiary Company Any other transaction Revenue Share 0.00 Not Applicable 0.00 19-03-2026 5,445.26 4,287.70 4,685.10 Any other NA 0 Not Applicable
121 HealthCare Global Enterprises Limited Nagpur Cancer Hospital and Research Institute Pvt Ltd Subsidiary Company Any other transaction Excpected credit loss recognised on trade receivables 0.00 Not Applicable 0.00 19-03-2026 178.50 824.00 1,002.50 Any other NA 0 Not Applicable
122 HealthCare Global Enterprises Limited Cancer Care Kenya Limited Wholly - owned subsidiary LLP Investment 695.20 Approved 0.00 19-03-2026 695.20 0.00 695.20 Any other NA 0 Not Applicable
123 HealthCare Global Enterprises Limited HCG (Mauritius) Private Limited Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0.00 Not Applicable 0.00 19-03-2026 7.10 7.30 14.50 Any other NA 0 Not Applicable
124 HealthCare Global Enterprises Limited International Human Development and Upliftment Academy (Trust) Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction CSR contribution to 126.90 Approved 0.00 19-03-2026 126.90 0.00 0.00 Any other NA 0 Not Applicable
125 HealthCare Global Enterprises Limited Rajiv Maliwal Independent Directors Any other transaction Sitting fees to Directors 20.65 Approved 0.00 19-03-2026 20.65 0.00 0.00 Any other NA 0 Not Applicable
126 HealthCare Global Enterprises Limited Pradip M. Kanakia Independent Directors Any other transaction Sitting fees to Directors 20.65 Approved 0.00 19-03-2026 20.65 0.00 0.00 Any other NA 0 Not Applicable
127 HealthCare Global Enterprises Limited Geeta Mathur Independent Directors Any other transaction Sitting fees to Directors 20.65 Approved 0.00 19-03-2026 20.65 0.00 0.00 Any other NA 0 Not Applicable
128 HealthCare Global Enterprises Limited Rajagopalan Raghavan Independent Directors Any other transaction Sitting fees to Directors 20.65 Approved 0.00 19-03-2026 20.65 0.00 0.00 Any other NA 0 Not Applicable
129 HealthCare Global Enterprises Limited Amit Soni Non-executive directors Any other transaction NA 0.00 Not Applicable 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable Textual Information(1)
130 HealthCare Global Enterprises Limited Siddharth Patel Non-executive directors Any other transaction NA 0.00 Not Applicable 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable Textual Information(2)
131 HealthCare Global Enterprises Limited Akshay Tanna Non-Executive Non-Independent Director Any other transaction NA 0.00 Not Applicable 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable Textual Information(3)
132 HealthCare Global Enterprises Limited Simrun Mehta Non-Executive Non-Independent Director Any other transaction NA 0.00 Not Applicable 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable Textual Information(4)
133 HealthCare Global Enterprises Limited Bijou Kurien Independent Directors Any other transaction Sitting fees to Directors 31.00 Approved 0.00 19-03-2026 31.00 0.00 0.00 Any other NA 0 Not Applicable Textual Information(5)
134 HealthCare Global Enterprises Limited Dr. B S Ajaikumar Whole-time director Remuneration 0.00 Approved 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable Textual Information(6)
135 HealthCare Global Enterprises Limited Dr. B S Ajaikumar Non-Executive Director, Promoter Any other transaction Medical Consultant fee 166.68 Approved 0.00 19-03-2026 166.68 29.99 33.50 Any other NA 0 Not Applicable Textual Information(7)
136 HealthCare Global Enterprises Limited Dr. B S Ajaikumar Non-Executive Director, Promoter Any other transaction Professional fees 200.00 Approved 0.00 19-03-2026 200.00 0.00 0.00 Any other NA 0 Not Applicable
137 HealthCare Global Enterprises Limited Ms. Anjali Ajaikumar Key Managerial Personnel Remuneration 0.00 Not Applicable 0.00 19-03-2026 0.00 0.00 0.00 Any other NA 0 Not Applicable Textual Information(8)
138 HealthCare Global Enterprises Limited Ms. Anjali Ajaikumar Non-Execuitve Director Any other transaction Professional Services 0.00 Not Applicable 0.00 19-03-2026 74.03 10.25 0.00 Any other NA 0 Not Applicable Textual Information(9)
139 HealthCare Global Enterprises Limited Meghraj Arvindrao Gore Key Managerial Personnel Remuneration 0.00 Not Applicable 0.00 19-03-2026 25.70 27.77 0.00 Any other NA 0 Not Applicable Textual Information(10)
140 HealthCare Global Enterprises Limited Meghraj Arvindrao Gore Key Managerial Personnel Any other transaction Share based payments 0.00 Not Applicable 0.00 19-03-2026 1,723.97 0.00 0.00 Any other NA 0 Not Applicable Textual Information(11)
141 HealthCare Global Enterprises Limited Ruby Ritolia Key Managerial Personnel Remuneration 0.00 Not Applicable 0.00 19-03-2026 2.40 7.01 0.00 Any other NA 0 Not Applicable Textual Information(12)
142 HealthCare Global Enterprises Limited Ruby Ritolia Key Managerial Personnel Any other transaction Share based payments 0.00 Not Applicable 0.00 19-03-2026 208.44 0.00 0.00 Any other NA 0 Not Applicable Textual Information(13)
143 HealthCare Global Enterprises Limited Sunu Manuel Key Managerial Personnel Remuneration 0.00 Not Applicable 0.00 19-03-2026 30.09 12.48 25.40 Any other NA 0 Not Applicable
144 HealthCare Global Enterprises Limited Sunu Manuel Key Managerial Personnel Any other transaction Share based payments 0.00 Not Applicable 0.00 19-03-2026 0.73 0.00 0.00 Any other NA 0 Not Applicable
145 HealthCare Global Enterprises Limited Dr Manish Mattoo Key Managerial Personnel Remuneration 0.00 Not Applicable 0.00 19-03-2026 177.41 86.19 80.50 Any other NA 0 Not Applicable Textual Information(14)
Total value of transaction during the reporting period 46,801.55



Text Block

Textual Information(1) up to 30 May 2025
Textual Information(2) up to 30 May 2025
Textual Information(3) w.e.f 30 May 2025
Textual Information(4) w.e.f 30 May 2025
Textual Information(5) w.e.f 30 May 2025
Textual Information(6) Upto 29 June 2025
Textual Information(7) W.e.f 30 June 2025
Textual Information(8) Upto 29 June 2025
Textual Information(9) W.e.f 30 June 2025
Textual Information(10) Up to 30 June 2025
Textual Information(11) Up to 30 June 2025
Textual Information(12) Upto 02 September 2025
Textual Information(13) Upto 02 September 2025
Textual Information(14) W.e.f 30 June 2025